States : Actualité States en direct - P1 | Bourse Reflex
Accueil > Tags > States

  • Toutes les actualités en rapport avec « States »

02/05 07:30 States - ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER

30/04 12:10 States - Availability of the 2017 annual financial report

30/04 07:00 States - PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION / LIQUIDITY CONTRACT ENTERED INTO WITH LOUIS CAPITAL MARKETS

27/04 18:00 States - Prismaflex International completed the acquisition of 50% of Anthem Displays, LLC

27/04 07:30 States - Antalis International - First-quater 2018 results

26/04 18:40 States - STRONG GROWTH IN 2017 RESULTS : TURNOVER: +22.8% - OPERATING INCOME: +49.5% - VERY HEALTHY FINANCIAL POSITION

26/04 18:00 States - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

25/04 18:00 States - EXCELLENTS RÉSULTATS ANNUELS 2017 ET PROPOSITION DE DISTRIBUTION D'UN DIVIDENDE DE 0,30 EUR PAR ACTION, EN HAUSSE DE 25%

25/04 15:00 States - Quadpack ramps up US activity with new appointment, new distributor

23/04 07:30 States - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:00 States - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

19/04 18:00 States - H1 2017-2018 REVENUES UP 17%

19/04 18:00 States - ATEME REVEALS 3 MAJOR INNOVATION PRIORITIES AT NAB 2018

19/04 17:45 States - Quantum Genomics enters a new phase of maturity with its BAPAIs Fast Growth strategic plan

18/04 18:00 States - ANNUAL REVENUE AS OF MARCH 31, 2018

12/04 21:25 States - 12/04/2018 - Successful pricing of a new 10-year bond issue of EUR 700 million

10/04 07:30 States - Full-Year 2017 results

09/04 18:00 States - Quantum Genomics strengthens its governance

04/04 11:45 States - INFRA PARK TO OFFER NEW BONDS

03/04 16:00 States - Half year results 2017/18 - Confirmation of the objectives set out in the business development plan: EUR 250M and 10% EBITDA by 2021